C1 esterase inhibitor recombinant Intravenous and Omalizumab Subcutaneous
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, and Ritonavir
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- C1 esterase inhibitor recombinant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- C1 esterase inhibitor recombinant Intravenous-Omeclamox-Pak
- C1 esterase inhibitor recombinant Intravenous-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-C1 esterase inhibitor, human Intravenous
- Omalizumab Subcutaneous-C1 Inhibitor (Human)
- Omalizumab Subcutaneous-C1 Inhibitor (Human) (Berinert)
- Omalizumab Subcutaneous-C1 Inhibitor (Human) (Cinryze)
- Omalizumab Subcutaneous-C1 Inhibitor (Human) (Haegarda)
- Omalizumab Subcutaneous-C1 Inhibitor (Recombinant)